Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperglycemia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia 2 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hyperphagia 1 Diabetes Mellitus, Type 2 1 Congenital Abnormalities 1 Burkitt Lymphoma 1

Interventions

Metformin 30 Exercise 8 Pioglitazone 7 Inositol 6 Insulin 5 Acupuncture Therapy 4 High-Intensity Interval Training 3 Ethinyl Estradiol 3 salicylsalicylic acid 2 drospirenone and ethinyl estradiol combination 2 Water 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Resistance Training 2 Preoperative Exercise 2 Observation 2 Folic Acid 2 Diet Therapy 2 Cyproterone Acetate 2 Cholecalciferol 2 Caloric Restriction 2 Biguanides 2 ziprasidone 1 maltodextrin 1 lime 1 licogliflozin 1 exendin (9-39) 1 drospirenone 1 cinnulin PF 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Insulin Resistance × Insulin Glargine × Clear all

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡